Overview
Split cord malformation type I (SCM type I), also known as diastematomyelia type I, is a rare congenital spinal dysraphism in which the spinal cord is divided into two hemicords by a rigid osseocartilaginous (bony or cartilaginous) septum or spur. Each hemicord is contained within its own separate dural tube. This distinguishes it from type II split cord malformation, where the two hemicords share a single dural sac and are separated by a fibrous septum. The condition results from a developmental defect during embryogenesis, likely related to abnormal formation of the notochord and persistence of an accessory neurenteric canal. Split cord malformation type I primarily affects the nervous system and musculoskeletal system. The bony septum tethers the spinal cord, leading to progressive neurological deterioration as the child grows. Key clinical features include lower limb weakness or asymmetry, foot deformities (such as clubfoot), gait abnormalities, back pain, scoliosis, and neurogenic bladder or bowel dysfunction. Cutaneous stigmata overlying the affected spinal segment — such as a hairy patch (hypertrichosis), dimple, lipoma, or hemangioma — are frequently present and may serve as early diagnostic clues. Symptoms may present in infancy or childhood but can occasionally remain undiagnosed until adulthood if neurological deficits are mild. Diagnosis is typically confirmed through MRI of the spine, often supplemented by CT scanning to visualize the bony septum. Treatment is surgical and involves removal of the osseocartilaginous septum and untethering of the spinal cord to prevent further neurological deterioration. Early surgical intervention generally yields better outcomes, particularly in preserving neurological and urological function. Postoperative monitoring is important, as re-tethering can occur. There is no cure for existing neurological damage, and rehabilitation including physiotherapy and management of bladder dysfunction may be necessary as part of long-term care.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Split cord malformation type I.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Split cord malformation type I at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Split cord malformation type I.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Split cord malformation type I.
Community
No community posts yet. Be the first to share your experience with Split cord malformation type I.
Start the conversation →Latest news about Split cord malformation type I
No recent news articles for Split cord malformation type I.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Split cord malformation type I
What is Split cord malformation type I?
Split cord malformation type I (SCM type I), also known as diastematomyelia type I, is a rare congenital spinal dysraphism in which the spinal cord is divided into two hemicords by a rigid osseocartilaginous (bony or cartilaginous) septum or spur. Each hemicord is contained within its own separate dural tube. This distinguishes it from type II split cord malformation, where the two hemicords share a single dural sac and are separated by a fibrous septum. The condition results from a developmental defect during embryogenesis, likely related to abnormal formation of the notochord and persistence
How is Split cord malformation type I inherited?
Split cord malformation type I follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.